Two rare complications of glioblastoma multiforme: Persistent hiccup and acquired haemophilia A

Netherlands Journal of Medicine

Volumn 66, Issue 7, 2008, Pages 286-288

  van Durme, C M P G ^a   Idema, R N ^a   van Guldener, C ^a  

^a AMPHIA HOSPITAL   (Netherlands)

Author keywords

Glioblastoma; Haemophilia; Hiccups

Indexed keywords

BACLOFEN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; DESMOPRESSIN; DEXAMETHASONE; DIAZEPAM; HEMOGLOBIN; METOCLOPRAMIDE; PIRACETAM; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

AGED; ARTICLE; BRAIN SURGERY; CASE REPORT; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; GLIOBLASTOMA; GRAND MAL SEIZURE; HEMATURIA; HEMOPHILIA A; HICCUP; HUMAN; MALE; MELENA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; RETROPERITONEAL HEMATOMA; SINGLE DRUG DOSE; SKIN BLEEDING; TEMPORAL LOBE; THROMBOCYTE COUNT;

AGED; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FACTOR VII; GLIOBLASTOMA; HEMOPHILIA A; HICCUP; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TEMPORAL LOBE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48749129433     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kasper CK, Aledort LM, Aronson D, et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:869-72.
2. Lewis JH. Hiccups: causes and cures. J Clin Gastroenterol 1985;7:539.52.
3. Kolodzik PW, Eilers MA. Hiccups (singultus): review and approach to management. Ann Emerg Med 1991;20:565-73.
4. Jansen PH, Joosten EM, Vingerhoets HM. Persistent periodic hiccups following brain abscess: a case report. J Neurol Neurosurg Psychiatry 1990;53:83.4.
5. Marsot-Dupuch K, Bousson V, Cabane J, Tubiana JM. Intractable hiccups: the role of cerebral MR in cases without systemic cause. Am J Neuroradiology 1995;16:2093-100.
6. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007;109:1870-7.
7. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21-35.
8. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981;45:200-3.
9. Hay CR, Negrier C, Ludlam C. The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997;78:1463-7.
10. Lollar P. Pathogenic antibodies to coagulation factors. Part one: Factor VIII and factor IX. J Thromb Haemost 2004;2:1082-95.
11. Hauser I, Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost 1999;82:1005-7.
12. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001;91:1067-74.
13. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006;133:591-605.
14. Biggs R, Austen DE, Denson KW, Borrett R, Rizza CR. The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Br J Haematol 1972;23:137-55.